Drawing for RECO2VERY THERAPIES

USPTO serial 90478078

RECO2VERY THERAPIES

Reviewed by CopyMark Law Group

Reg. 6887001Status 700Registered
Filing date
Status date
Registration date
Nov 1, 2022
Examiner
LOVELACE, JAMES B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RECO2VERY THERAPIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret C. McHugh

Margaret C. McHugh KILPATRICK TOWNSEND & STOCKTON LLPTwo Embarcadero Center,Suite 1900San Francisco, CA 94111

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and veterinary preparations for the treatment of cardiovascular diseases, heart and circulatory diseases, heart failure, coronary diseases, endovascular diseases, structural heart diseasesACTIVE—
010Surgical, medical, and veterinary apparatus and instruments, namely, surgical or medical devices for treating structural heart diseases, surgical or medical devices for treating heart failure, surgical or medical devices for providing endovascular therapy, heart and lung assist devices, catheters, stents such as coated stents or self-expanding stents, obliteration devices, occlusion devices, implantable ventricular devices, cannulas; Suture materials; Catheters, in particular balloon catheters; Medical apparatus and instruments for treating structural heart disease; Medical devices to treat heart failure; Medical devices for endovascular therapy; Heart and lung support devices, namely, stents, lung ventilators, implantable ventricular assist devices such as implantable left or right ventricular assist devices, permanent implantable ventricular assist devices; Stents in particular coated stents or self-expanding stents; Obliteration devices, namely, left atrial appendage (LAA) obliteration devices, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Occlusion devices, namely, catheters, stents, patent foramen ovale (PFO) occlusion devices; atrial septal defect (ASD) occlusion devices; ventricular septal defect (VSD) occlusion devices; Implantable ventricular devices, namely, intravascular implants comprised of artificial material or implantable ventricular assist devices; CannulaeACTIVE—
044Medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 1, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2022DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Sep 27, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 12, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 12, 2022D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jun 7, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 12, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 12, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 10, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2021DOCKASSIGNED TO EXAMINER—
May 21, 2021AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
May 21, 2021ALIEASSIGNED TO LIE—
Apr 22, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 17, 2021PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 23, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance